This is a non-core endpoint: only basic statistics are computed.
Other superficial injuries of ankle and foot
ST19_OTHER_SUPERF_INJURI_ANKLE_FOOT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
227 |
4. Check minimum number of eventsNone |
227 |
5. Include endpointsNone |
227 |
6. Filter based on genotype QC (FinnGen only) |
227 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Aliae laesiones superficiales specificatae tarsi/pedis
Similar endpoints
↥List of similar endpoints to
Other superficial injuries of ankle and foot
based on the number of shared cases.
Similar with more cases:
- Superficial injury of ankle and foot
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 227 | 130 | 97 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 43.73 | 38.35 | 50.95 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 206
- Matched controls
- 2061
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S90.8
ICD-10 Finland
Other superficial injuries of ankle and foot
+∞
293.9
206
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
13.8
26.0
46
42
X59
ICD-10 Finland
Exposure to unspecified factor
5.3
19.2
67
173
S93.4
ICD-10 Finland
Sprain and strain of ankle
6.3
12.8
35
65
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
9.0
12.8
27
34
X58
ICD-10 Finland
Exposure to other specified factors
4.3
12.2
49
140
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.3
11.8
70
277
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
12.2
11.3
20
18
NH1AD
NOMESCO Finland
Ankle and foot CT
23.0
10.8
15
7
L17
ICPC
Foot/toe symptom/complaint
3.2
10.7
65
259
W22
ICD-10 Finland
Striking against or struck by other object(s)
5.5
10.4
31
64
W17
ICD-10 Finland
Other fall from one level to another
7.0
8.7
21
33
M79.6
ICD-10 Finland
Pain in limb
2.7
8.7
74
357
S92.3
ICD-10 Finland
Fracture of metatarsal bone
15.3
8.3
13
9
W19
ICD-10 Finland
Unspecified fall
4.5
8.1
28
69
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
13.8
8.0
13
10
S80.0
ICD-10 Finland
Contusion of knee
4.9
6.7
21
47
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
9.7
6.4
12
13
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
6.2
116
785
D11
ICPC
Diarrhoea
3.2
6.1
31
108
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
68
383
2.11
5.79
3.7
4.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
275
2.16
5.15
1.3
1.3
u/ml
3.9
8.2
0.64
17
122
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
20
5.18
4.82
2.3
4.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
162
1281
1.92
4.72
4.6
3.9
mm/h
10.7
9.8
0.33
148
1183
(3045414) Leukocytes [Presence] in Urine
18
59
3.23
4.63
2.7
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
30
4.17
4.49
3.3
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
47
253
2.08
4.42
3.4
3.0
e6/l
2.6
3.0
0.07
29
133
(42870588) Differential panel, method unspecified - Blood
87
585
1.79
4.18
7.8
6.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
64
2.97
4.06
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
102
2.51
3.89
2.9
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
103
740
1.72
3.85
9.2
7.7
mmol/l
1.2
1.2
0.52
93
624
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
50
289
1.94
3.83
1.4
1.3
iu/ml
35.2
25.3
—
5
92
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
61
2.93
3.78
2.7
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
84
582
1.70
3.52
2.1
1.9
pmol/l
97.7
93.5
0.37
40
307
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
237
1.95
3.44
2.5
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
389
1.78
3.41
1.8
2.1
mg/l
1.2
1.1
0.08
44
299
(3013512) EKG study
63
406
1.76
3.40
3.5
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
263
1.89
3.32
3.1
2.9
e6/l
0.5
0.7
0.44
27
144
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
96
701
1.64
3.24
3.0
2.5
nmol/l
73.3
73.0
0.03
89
638
(36304419) Bacteria [Presence] in Urine
67
447
1.71
3.18
4.1
2.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
164
1387
1.66
2.91
4.1
4.0
pmol/l
14.4
14.6
0.65
149
1284
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
80
571
1.62
2.89
4.3
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
65
443
1.65
2.81
4.3
3.0
e6/l
0.2
0.3
0.25
52
319
(3048689) Calprotectin [Mass/mass] in Stool
45
278
1.77
2.77
2.5
2.4
ug/g
202.6
115.0
0.32
36
222
(3032080) INR in Blood by Coagulation assay
79
568
1.60
2.75
8.1
6.5
inr
1.4
1.2
1.10
18
174
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
14
5.12
2.75
1.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
14
5.12
2.75
1.0
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
52
336
1.71
2.74
3.5
2.3
e6/l
4.0
5.4
0.77
45
290
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
37
3.07
2.73
1.5
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
90
676
1.55
2.57
8.4
7.0
mmol/l
1.2
1.2
0.21
85
618
(3000330) Specific gravity of Urine by Test strip
16
69
2.42
2.55
3.5
3.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
81
596
1.56
2.52
5.4
3.6
e6/l
24.0
65.9
0.67
62
397
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
57
2.55
2.50
2.5
2.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
37
223
1.79
2.47
2.4
2.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
90
2.21
2.47
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
68
484
1.58
2.44
4.5
3.3
mmol/l
7.8
8.1
0.14
59
421
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
169
1469
1.59
2.39
3.9
3.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
22
3.73
2.38
6.5
13.9
%
58.9
68.8
—
8
22
(3002582) Erythrocytes [#/volume] in Urine
69
499
1.55
2.29
4.8
3.1
e6/l
18.3
175.8
0.63
58
373
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
23
3.57
2.29
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
23
3.57
2.29
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
23
3.57
2.29
1.5
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
13
4.71
2.28
3.3
22.2
%
8.1
13.8
—
6
13
(3026782) Osmolality of Urine
48
319
1.64
2.26
3.6
2.7
mosm/kgh2o
524.0
583.6
0.92
43
266
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
54
2.49
2.24
1.2
1.5
—
256.0
—
0
5
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
24
3.42
2.20
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
24
3.42
2.20
1.5
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
24
3.42
2.20
7.3
14.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
24
3.42
2.20
1.5
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
186
1669
1.63
2.14
4.6
3.9
mmol/l
5.9
5.8
0.35
175
1551
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
42
275
1.65
2.10
4.9
3.0
ng/l
172.1
247.7
0.17
29
175
(3009542) Hematocrit [Volume Fraction] of Blood
195
1774
1.70
2.08
18.4
12.8
%
40.1
40.5
0.27
161
1434
(3037522) Nuclear Ab [Titer] in Serum
38
243
1.68
2.07
1.8
1.3
titre
628.6
420.0
—
7
56
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
56
395
1.55
2.06
1.7
2.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
38
2.71
2.04
1.3
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
57
2.36
2.02
4.1
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
39
2.64
1.95
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
444
1.51
1.94
1.8
1.7
mmol/l
1.4
1.4
0.20
55
386
(3012516) Albumin [Mass/volume] in Urine
55
392
1.53
1.93
4.4
3.2
mg/l
66.8
94.8
0.37
36
256
(3019069) Monocytes/100 leukocytes in Blood
107
871
1.43
1.92
8.4
6.5
%
8.2
8.3
0.21
99
831
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
51
358
1.55
1.91
1.7
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
200
1844
1.71
1.87
17.8
11.9
mg/l
21.9
21.2
0.08
161
1424
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
152
1323
1.45
1.86
3.1
3.1
u/l
44.9
42.9
0.07
142
1254
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
18
94
1.99
1.86
1.1
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
106
865
1.42
1.86
8.2
6.1
%
2.8
2.9
0.08
97
814
(3013115) Eosinophils [#/volume] in Blood
115
953
1.42
1.84
8.3
6.8
e9/l
0.2
0.2
0.36
104
855
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
163
1.75
1.81
2.4
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
103
840
1.41
1.80
8.3
6.2
%
0.7
0.7
0.08
95
794
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
164
1.73
1.78
2.4
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
24
2.98
1.73
1.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
13
3.91
1.72
1.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
33
214
1.63
1.72
1.2
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
50
358
1.51
1.71
1.6
1.5
nmol/l
19.4
20.3
0.22
41
312
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
55
2.25
1.70
2.4
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
104
857
1.39
1.68
3.7
2.9
ug/l
86.8
88.1
0.04
94
810
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
56
2.21
1.64
2.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
86
690
1.40
1.61
2.4
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
71
551
1.42
1.61
2.4
2.2
—
—
—
0
0
(3036489) Thrombin time
15
78
1.99
1.58
1.5
3.3
s
24.9
21.9
0.31
15
69
(3020682) Albumin/Creatinine [Ratio] in Urine
56
418
1.45
1.56
5.5
3.9
mg/mmol
15.0
13.1
0.09
40
276
(3026008) Bacteria identified in Urine by Culture
61
463
1.43
1.55
3.8
2.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
47
339
1.49
1.55
2.8
2.9
ng/l
898.5
850.1
0.07
41
274
(3002030) Lymphocytes/100 leukocytes in Blood
108
905
1.37
1.54
8.1
6.2
%
30.2
29.3
0.38
100
865
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
21
2.91
1.51
1.2
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
183
1676
1.47
1.51
5.1
4.5
mu/l
1.8
1.8
0.36
167
1558
(4010399)
20
118
1.76
1.47
1.8
1.5
—
—
—
0
0
(3019225) pH of Specimen
23
142
1.69
1.45
6.7
4.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
22
2.77
1.44
1.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
111
1.78
1.44
3.4
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
106
893
1.35
1.43
8.0
6.0
%
55.4
56.4
0.38
99
850
(3035637) Corticotropin [Mass/volume] in Plasma
6
23
2.65
1.37
1.2
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
187
1729
1.46
1.37
4.5
3.8
mmol/l
1.4
1.4
1.29
173
1626
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
64
501
1.39
1.36
1.5
1.3
u/ml
1.1
2.0
0.48
15
144
(3007164) IgA [Mass/volume] in Serum or Plasma
59
456
1.40
1.35
1.7
1.5
g/l
2.3
2.2
0.03
29
288
(3027008) Opiates [Presence] in Urine
22
137
1.67
1.35
3.1
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
53
402
1.42
1.35
3.0
2.1
mg/l
2.7
2.8
0.15
41
348
(3011288) Drugs identified in Urine by Screen method
16
91
1.82
1.33
4.2
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
138
1.66
1.32
3.1
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
18
2.82
1.29
1.4
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
22
139
1.65
1.29
3.2
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
187
1736
1.44
1.27
4.4
3.9
mmol/l
4.6
4.7
0.44
172
1635
(3018418) pH of Serum or Plasma
57
443
1.38
1.26
6.6
3.9
ph
7.4
7.4
—
7
78
(3011397) Hemoglobin [Presence] in Urine by Test strip
49
371
1.41
1.26
3.3
3.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
93
1.78
1.25
6.1
12.2
mmol/l
24.3
24.7
0.17
16
93
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
14
78
1.85
1.24
4.3
3.1
ng/l
161.6
160.7
0.00
14
70
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
67
537
1.35
1.23
4.1
3.1
ng/l
24.6
35.4
0.38
47
310
(3019060) Gas panel - Arterial blood
15
86
1.80
1.22
4.7
9.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
189
1762
1.43
1.22
4.8
4.2
mmol/l
2.8
2.8
0.02
170
1657
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
26
2.34
1.19
2.3
2.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
126
1.64
1.19
3.4
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
59
467
1.36
1.17
9.6
6.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
111
1.68
1.16
2.4
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
20
2.53
1.15
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
107
924
1.30
1.15
8.5
6.2
e9/l
0.0
0.0
0.72
96
813
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
40
2.04
1.13
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
51
2.01
1.13
1.1
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
21
137
1.59
1.10
3.2
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
19
121
1.62
1.09
10.4
8.5
mmol/l
1.3
1.3
0.03
19
113
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
169
1559
1.33
1.07
5.7
4.9
mmol/mol
39.1
38.9
0.09
155
1478
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
33
2.16
1.06
1.6
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
33
2.16
1.06
1.6
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
98
1.68
1.06
1.2
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
46
2.00
1.05
1.3
2.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
22
2.30
1.04
1.2
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
421
1.34
1.02
2.3
2.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
106
925
1.27
1.02
8.5
6.1
e9/l
0.6
0.6
0.23
95
812
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
97
838
1.28
1.01
3.6
4.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
29
208
1.45
1.01
2.0
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
497
1.31
0.99
1.4
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
94
812
1.27
0.97
10.7
8.6
e9/l
0.0
0.0
0.82
82
654
(36660697) Celiac disease serology panel - Serum
27
193
1.45
0.96
1.4
1.2
—
—
—
0
0
(3012544) pH of Venous blood
20
134
1.54
0.95
10.6
7.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
37
1.92
0.95
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
37
1.92
0.95
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
136
1231
1.26
0.93
5.5
4.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
55
1.86
0.93
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
110
1.59
0.93
3.6
3.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
264
0.65
0.93
1.4
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
9
52
1.76
0.93
1.6
1.2
—
64.0
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
178
1666
1.32
0.93
3.9
3.5
mmol/l
1.4
1.3
0.63
165
1563
(3044889) 12 lead EKG panel
124
1113
1.25
0.91
3.8
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
142
1295
1.26
0.90
9.1
7.3
u/l
73.8
78.3
0.71
135
1218
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
177
1660
1.30
0.87
16.6
10.0
ml/min/173m2
88.8
90.0
0.28
156
1316
(3022145) Colonoscopy Study observation
24
171
1.45
0.87
1.3
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
108
959
1.24
0.86
8.6
6.2
e9/l
2.0
1.9
0.85
97
861
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
31
1.96
0.85
1.5
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
8
46
1.77
0.83
1.6
14.6
%
1.0
0.9
—
8
40
(3004588) Protein electrophoresis panel - Serum or Plasma
14
89
1.61
0.83
1.4
2.6
—
—
—
0
0
(3039000) Anion gap in Blood
6
32
1.90
0.82
1.7
20.1
mmol/l
12.0
11.1
—
6
26
(3018572) Chloride [Moles/volume] in Blood
6
32
1.90
0.82
1.7
20.1
mmol/l
104.7
104.8
—
6
26
(1002224) Polysomnography panel
14
90
1.59
0.80
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
25
183
1.41
0.80
1.9
2.1
nmol/l
370.4
375.4
0.05
25
170
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
8
48
1.69
0.79
1.6
14.0
%
1.5
1.7
—
8
41
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
202
1937
1.39
0.79
11.9
9.3
u/l
28.0
26.6
0.52
195
1877
(4306422)
6
34
1.78
0.77
1.2
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
6
34
1.78
0.77
1.7
1.1
—
14.9
—
0
7
(3013650) Neutrophils [#/volume] in Blood by Automated count
117
1057
1.22
0.76
9.8
9.7
e9/l
3.9
4.1
0.50
107
931
(3025159) Blasts/100 leukocytes in Blood
18
125
1.48
0.75
7.3
5.0
%
0.0
0.0
—
10
29
(3045424) Erythrocytes [Presence] in Urine
5
24
2.11
0.75
1.4
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
24
2.11
0.75
1.2
1.8
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
5
25
2.02
0.73
1.4
1.1
%
77.6
97.1
—
5
25
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
68
1.65
0.73
2.0
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
96
854
1.22
0.72
5.0
5.0
estimate
0.0
0.0
0.00
16
169
(3050129) First trimester maternal screen panel - Serum or Plasma
9
146
0.60
0.72
1.3
1.5
—
—
—
0
0
(4268621)
5
26
1.94
0.71
2.2
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
69
1.62
0.69
11.4
15.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
86
1.54
0.67
1.4
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
96
859
1.20
0.67
3.6
3.5
estimate
0.0
0.0
0.00
16
167
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
29
1.74
0.64
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
29
1.74
0.64
1.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
50
1.62
0.62
3.0
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
526
1.22
0.62
4.2
3.1
mmol/l
2.3
2.3
0.12
53
466
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
52
1.56
0.60
1.4
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
96
867
1.19
0.59
3.6
3.5
estimate
0.0
0.0
0.00
15
166
(3021440) Promyelocytes/100 leukocytes in Blood
18
132
1.39
0.59
7.4
4.9
%
0.0
0.2
—
10
36
(3003327) Ova and parasites identified in Stool by Light microscopy
12
81
1.51
0.58
1.8
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
205
0.71
0.57
2.4
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
89
0.55
0.57
1.4
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
90
1.47
0.57
1.6
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
55
1.47
0.56
2.4
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
18
134
1.37
0.55
3.3
2.6
e9/l
3.5
3.9
0.29
11
114
(3043409) Potassium [Moles/volume] in Arterial blood
6
38
1.59
0.54
8.7
4.4
mmol/l
3.8
3.9
—
6
32
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
39
1.55
0.53
1.0
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
40
1.51
0.52
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
84
1.45
0.50
4.3
4.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
45
1.57
0.49
1.4
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
19
146
1.33
0.49
9.7
9.9
kpa
4.9
5.0
0.05
19
138
(3027801) Oxygen [Partial pressure] in Arterial blood
19
146
1.33
0.49
9.8
9.8
kpa
12.0
13.2
0.48
19
139
(3047181) Lactate [Moles/volume] in Blood
7
46
1.54
0.48
2.1
15.8
mmol/l
1.6
1.2
—
7
39
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
120
1.36
0.47
1.9
2.3
ml/min/173m2
77.4
78.9
—
9
53
(3016502) Oxygen saturation in Arterial blood
17
129
1.34
0.47
10.6
11.0
%
96.2
96.4
0.05
17
122
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
23
183
1.29
0.47
5.2
3.8
%
31.6
31.7
0.01
15
128
(40761511) CBC panel - Blood by Automated count
201
1954
1.25
0.45
14.4
10.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
51
1.38
0.44
3.7
2.9
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
91
0.65
0.43
1.5
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
91
0.65
0.43
1.5
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
31
1.63
0.43
3.2
1.3
g/l
0.8
0.6
—
5
24
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
95
0.62
0.43
1.7
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
32
1.57
0.42
1.2
1.2
—
6.6
—
0
14
(3017181) Myelocytes/100 leukocytes in Blood
18
141
1.30
0.41
7.4
4.7
%
1.2
0.8
—
10
41
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
1.0
—
0
15
(3016244) Insulin [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.8
—
14.3
—
0
15
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
4.1
—
22.6
—
0
18
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
8
61
1.32
0.40
1.8
1.2
g/l
1.3
1.2
—
8
56
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
8
61
1.32
0.40
1.9
2.1
g/l
1.3
1.5
—
8
54
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
169
0.76
0.38
1.9
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
125
1.30
0.38
1.6
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
27
226
1.22
0.38
1.5
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
11
81
1.38
0.37
8.1
12.6
mmol/l
23.5
24.0
0.10
11
73
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
99
1.33
0.36
1.5
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
16
126
1.29
0.36
7.7
4.5
%
2.0
0.5
—
8
22
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
121
0.73
0.36
1.4
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
44
1.37
0.34
1.5
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
16
127
1.28
0.34
17.9
8.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
208
0.80
0.33
1.4
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
43
382
1.16
0.32
3.0
3.8
kg/l
1.0
1.0
—
9
56
(46235355) HIV 1 and 2 tests - Meaningful Use set
61
556
1.13
0.32
2.0
2.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
52
469
1.14
0.32
3.9
4.3
ug/l
1.8
1.8
0.01
46
427
(3019309) Folate [Moles/volume] in Red Blood Cells
29
251
1.18
0.30
1.8
1.6
nmol/l
731.6
1126.6
2.52
21
194
(3028626) Oxygen [Partial pressure] in Capillary blood
7
55
1.28
0.30
3.6
4.8
kpa
8.7
9.1
—
7
48
(3001019) Free T4 and TSH panel - Serum or Plasma
8
110
0.72
0.29
1.6
1.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
110
0.72
0.29
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
110
0.72
0.29
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
110
0.72
0.29
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
110
0.72
0.29
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
43
386
1.14
0.29
3.0
4.0
%
23.8
21.0
0.29
15
159
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
150
0.79
0.28
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
63
582
1.11
0.27
1.4
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
41
454
0.88
0.27
5.6
5.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
287
0.86
0.26
2.0
2.7
ug/l
0.7
0.7
0.06
13
167
(3041096) Erythrocytes [Presence] in Urine by Automated
48
525
0.89
0.26
3.4
3.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
74
1.23
0.25
1.1
1.7
nmol/l
39.2
40.2
—
9
74
(3015736) pH of Urine
73
684
1.10
0.24
3.3
3.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
39
1.29
0.23
1.6
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
135
1.20
0.22
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
10
0.00
0.21
0.0
1.3
—
57.0
—
0
10
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
12
0.00
0.21
0.0
3.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
2.7
—
0
9
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
59
1.19
0.18
1.6
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
272
1.12
0.18
2.0
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
138
1.17
0.18
3.1
2.3
u/l
2701.6
3092.2
—
5
59
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
60
1.17
0.18
1.6
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
61
1.15
0.17
1.6
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
7
61
1.15
0.17
13.3
3.9
mmol/l
24.0
24.7
—
7
61
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
62
1.13
0.17
1.7
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
322
1.10
0.16
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
246
1.11
0.15
2.2
1.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
13
112
1.17
0.14
6.5
4.1
kpa
4.9
5.0
0.22
13
101
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
96
0.83
0.14
1.4
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
34
316
1.09
0.13
1.7
1.7
pmol/l
522.3
54348260.6
0.80
28
276
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
222
1.09
0.10
1.7
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
74
716
1.05
0.10
2.5
2.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
48
1.04
0.09
3.0
2.4
—
—
—
0
0
(4034850)
5
48
1.04
0.09
9.4
12.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
308
0.93
0.09
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
165
1.10
0.09
7.5
5.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
6
57
1.05
0.08
1.3
1.6
—
0.0
—
0
13
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
66
1.06
0.08
1.3
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
66
680
0.96
0.08
3.4
3.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
78
1.03
0.07
1.6
1.7
—
—
—
0
0
(4035726)
13
118
1.11
0.07
1.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
87
1.04
0.07
1.7
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
172
0.92
0.06
1.6
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
119
1.10
0.06
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
37
358
1.04
0.04
1.7
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
147
0.95
0.01
3.6
3.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
45
444
1.02
0.00
1.9
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
149
1.01
0.00
4.8
3.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
159
1.01
0.00
1.3
1.2
iu/ml
97.9
160.0
—
5
58
(3000492) Spirometry study
20
201
0.99
0.00
2.1
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
219
1.01
0.00
1.5
1.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
8
0.00
0.00
0.0
5.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
17.2
—
0
6
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
65
0.92
0.00
1.5
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.1
—
730.1
—
0
9
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
61.1
—
0
5
(3006653) Thiamine [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
154.9
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
143.0
—
0
8
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.5
—
209.1
—
0
8
(3028433) Virus identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
46
460
1.00
0.00
3.5
3.6
estimate
0.0
0.0
0.50
15
166
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
71
0.99
0.00
1.1
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
1.2
—
0
5
(3009214) Lutropin [Units/volume] in Serum or Plasma
9
89
1.01
0.00
1.1
1.3
u/l
9.5
9.2
—
9
69
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
27.8
—
0
6
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.2
—
3699.4
—
0
5
(3045462) Protein/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
25.0
—
238.8
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
63
0.95
0.00
1.7
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.1
—
3.4
—
0
7
(3025577) Chromium [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.1
—
2.1
—
0
7
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4027681)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
6
0.00
0.00
0.0
1.3
—
192.8
—
0
6
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
69
0.87
0.00
1.7
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
88
0.91
0.00
1.0
1.8
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_OTHER_SUPERF_INJURI_ANKLE_FOOT – Other superficial injuries of ankle and foot
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).